These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5472870)

  • 1. The effect of inhibition of catecholamine synthesis on dexamphetamine induced central stimulation.
    Svensson TH
    Eur J Pharmacol; 1970 Oct; 12(2):161-6. PubMed ID: 5472870
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
    Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
    Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
    [No Abstract]   [Full Text] [Related]  

  • 3. Tyrosine hydroxylase inhibitors.
    Moore KE; Dominic JA
    Fed Proc; 1971; 30(3):859-70. PubMed ID: 4324974
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral and catecholamine depleting effects of alpha-methyl-5-hydroxytryptophan.
    Dominic JA; Moore KE
    Eur J Pharmacol; 1969 Dec; 8(3):292-5. PubMed ID: 5308817
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of apomorphine on motility in rats.
    Maj J; Grabowska M; Gajda L
    Eur J Pharmacol; 1972 Feb; 17(2):208-14. PubMed ID: 5026397
    [No Abstract]   [Full Text] [Related]  

  • 6. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between the effects of dexamphetamine on locomotion and on striatal [3H]GBR 12783 binding in vivo.
    Vaugeois JM; Bonnet JJ; Costentin J
    Eur J Pharmacol; 1990 Mar; 178(2):221-7. PubMed ID: 2328762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system effects of fenfluramine hydrochloride.
    Ziance RJ; Sipes IG; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain catecholamine release by dexamphetamine in three strains of mice.
    Dolfini E; Ramirez del Angel A; Garattini S; Valzelli L
    Eur J Pharmacol; 1970 Mar; 9(3):333-6. PubMed ID: 5440302
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-beta-hydroxylase.
    Corrodi H; Fuxe K; Ljungdahl A; Ogren SO
    Brain Res; 1970 Dec; 24(3):451-70. PubMed ID: 5494534
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of disulfiram and diethyldithiocarbamate on spontaneous locomotor activity and brain catecholamine levels in mice.
    Moore KE
    Biochem Pharmacol; 1969 Jul; 18(7):1627-34. PubMed ID: 5806105
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence that the CCENTRAL ACTION OF (+)-amphetamine is mediated via catecholamines.
    Hanson LC
    Psychopharmacologia; 1967; 10(4):289-97. PubMed ID: 5592154
    [No Abstract]   [Full Text] [Related]  

  • 14. Antagonism of D-amphetamine by alpha-methyl-L-tyrosine: behavioral evidence for the participation of catecholamine stores and synthesis in the amphetamine stimulant response.
    Stolk JM; Rech RH
    Neuropharmacology; 1970 May; 9(3):249-63. PubMed ID: 4393182
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
    Ahlenius S; Engel J
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of cycloheximide, diethyldithiocarbamate and D-amphetamine on protein and catecholamine biosynthesis in mouse brain.
    Bloom AS; Quinton EE; Carr LA
    Neuropharmacology; 1977 Jun; 16(6):411-8. PubMed ID: 198698
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 18. On the significance of central noradrenaline for motor activity: experiments with a new dopamine beta-hydroxylase inhibitor.
    Svensson TH; Waldeck B
    Eur J Pharmacol; 1969 Sep; 7(3):278-82. PubMed ID: 5351985
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.
    Bredeloux P; Dubuc I; Costentin J
    Br J Pharmacol; 2007 Mar; 150(6):711-9. PubMed ID: 17293887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that in rats 1-benzyl- -methoxy-3-trifluoromethylphenethylamine (SK& F 1-39728) dissociates anorexia from central stimulation and actions on brain monoamine stores.
    Groppetti A; Misher A; Naimzada M; Revuelta A; Costa E
    J Pharmacol Exp Ther; 1972 Sep; 182(3):464-73. PubMed ID: 5055405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.